Healthcare products – Contract manufacturing.
An expanded global footprint with orthopedic device OEMs will further enhance MedPlast’s medical business segment.
Attractiveness of medical plastics processing assets is extremely high and heading higher. As a result, there is significant payback in investment in new equipment for American medical molders and extruders. Venture capital firms that have invested heavily in America medical plastics processing assets in the last five years include: Kohlberg & Co. (Phillips Plastics), Baird Capital Partners and River Cities Capital Funds (MedPlast), and KRG Capital Partners (Vention).
River Cities Capital Fund IV invests in Medplast and Harold Faig joins the newly combined company as CEO.